Inventor · disambiguated record
Longqin Hu
Also filed as: HU LONGQIN
11 granted patents·3 pending applications·9 citations·filing 2003–2022
83Inventor score
Top patents by PatentIndex Score
14 records- 0187US10836737B2Cystine diamide analogs for the prevention of cystine stone formation in cystinuriaUNIV RUTGERS·Filed 2016·Granted Nov 17, 2020·3 cites·25 claims
- 0281US9428453B2Cystine diamide analogs for the prevention of cystine stone formation in cystinuriaUNIV RUTGERS·Filed 2014·Granted Aug 30, 2016·2 cites·4 claims
- 0378US10106502B2Direct inhibitors of Keap1-Nrf2 interaction as antioxidant inflammation modulatorsUNIV RUTGERS·Filed 2017·Granted Oct 23, 2018·2 cites·11 claims
- 0474US12391661B2Cystine diamide analogs for the prevention of cystine stone formation in cystinuriaUNIV RUTGERS·Filed 2022·Granted Aug 19, 2025·0 cites·8 claims
- 0573US11420949B2Cystine diamide analogs for the prevention of cystine stone formation in cystinuriaUNIV RUTGERS·Filed 2020·Granted Aug 23, 2022·0 cites·20 claims
- 0666US9075070B2HTS fluorescence polarization assay for inhibitors of Keap1-Nrf2 interactionHU LONGQIN·Filed 2012·Granted Jul 7, 2015·2 cites·8 claims
- 0760US11628221B2Peptide linker and combination for prodrugs activated by prostate-specific antigenUNIV RUTGERS·Filed 2021·Granted Apr 18, 2023·0 cites·18 claims
- 0850US2014256767A1Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulatorsUNIV RUTGERS·Filed 2012·Application pending·0 cites
- 0946US11129901B2Peptide-linked ester prodrugs activated by prostate-specific antigenUNIV RUTGERS·Filed 2018·Granted Sep 28, 2021·0 cites·20 claims
- 1045US12486241B2Cystine diamide analogs for cystinuriaUNIV RUTGERS·Filed 2020·Granted Dec 2, 2025·0 cites·20 claims
- 1141US8518891B2Chemotherapeutic conjugates and methods of useHU LONGQIN·Filed 2007·Granted Aug 27, 2013·0 cites·5 claims
- 1240US12122742B2Small molecule direct inhibitors of KEAP1-NRF2 protein-protein interactionUNIV RUTGERS·Filed 2020·Granted Oct 22, 2024·0 cites·21 claims
- 1335US2004214798A1Nitroaryl phosphoramide compositions and methods for targeting and inhibiting undesirable cell growth or proliferationFiled 2003·Application pending·0 cites
- 1429US2012322768A1Compounds, compositions and methods for treating protozoan infectionsHU LONGQIN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Longqin Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →